0 XP   0   0   0

Lavipharm S.A










Financial Health of Lavipharm




Comparing to competitors in the industry




  Industry Rankings  


Lavipharm S.A
Buy, Hold or Sell?

Should you buy, hold or sell Lavipharm?

I guess you are interested in Lavipharm S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Lavipharm

Let's start. I'm going to help you getting a better view of Lavipharm S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Lavipharm S.A even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Lavipharm S.A is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Lavipharm S.A. The closing price on 2022-12-01 was €0.35 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Lavipharm S.A Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.

1.1. Profitability of Lavipharm S.A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lavipharm earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Lavipharm to the  industry mean.
  • A Net Profit Margin of 0.0% means that €0.00 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lavipharm S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.3%-3.3%
TTM-5Y2.8%-2.8%
5Y2.8%10Y2.8%0.0%
1.1.2. Return on Assets

Shows how efficient Lavipharm is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lavipharm to the  industry mean.
  • 1.8% Return on Assets means that Lavipharm generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lavipharm S.A:

  • The MRQ is 1.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.5%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.8%TTM0.5%+1.3%
TTM0.5%YOY1.9%-1.4%
TTM0.5%5Y1.6%-1.1%
5Y1.6%10Y1.6%0.0%
1.1.3. Return on Equity

Shows how efficient Lavipharm is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lavipharm to the  industry mean.
  • 0.0% Return on Equity means Lavipharm generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lavipharm S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%

1.2. Operating Efficiency of Lavipharm S.A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lavipharm is operating .

  • Measures how much profit Lavipharm makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lavipharm to the  industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lavipharm S.A:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.7%-3.7%
TTM-5Y5.4%-5.4%
5Y5.4%10Y5.4%0.0%
1.2.2. Operating Ratio

Measures how efficient Lavipharm is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Lavipharm S.A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.290-0.290
TTM-5Y0.642-0.642
5Y0.64210Y0.6420.000

1.3. Liquidity of Lavipharm S.A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lavipharm is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.15 means the company has €1.15 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Lavipharm S.A:

  • The MRQ is 1.146. The company is just able to pay all its short-term debts.
  • The TTM is 1.132. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.146TTM1.132+0.014
TTM1.132YOY1.274-0.142
TTM1.1325Y1.182-0.051
5Y1.18210Y1.1820.000
1.3.2. Quick Ratio

Measures if Lavipharm is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lavipharm to the  industry mean.
  • A Quick Ratio of 0.55 means the company can pay off €0.55 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lavipharm S.A:

  • The MRQ is 0.552. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.587. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.552TTM0.587-0.035
TTM0.587YOY0.733-0.146
TTM0.5875Y0.680-0.093
5Y0.68010Y0.6800.000

1.4. Solvency of Lavipharm S.A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lavipharm assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lavipharm to industry mean.
  • A Debt to Asset Ratio of 1.18 means that Lavipharm assets are financed with 118.4% credit (debt) and the remaining percentage (100% - 118.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lavipharm S.A:

  • The MRQ is 1.184. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.184. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.184TTM1.1840.000
TTM1.184YOY1.229-0.044
TTM1.1845Y1.324-0.140
5Y1.32410Y1.3240.000
1.4.2. Debt to Equity Ratio

Measures if Lavipharm is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lavipharm to the  industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lavipharm S.A:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

2. Market Valuation of Lavipharm S.A

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Lavipharm generates.

  • Above 15 is considered overpriced but always compare Lavipharm to the  industry mean.
  • A PE ratio of 7.39 means the investor is paying €7.39 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lavipharm S.A:

  • The EOD is 6.270. Very good. +2
  • The MRQ is 7.389. Very good. +2
  • The TTM is -6.390. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD6.270MRQ7.389-1.120
MRQ7.389TTM-6.390+13.779
TTM-6.390YOY2,216.346-2,222.736
TTM-6.3905Y445.181-451.570
5Y445.18110Y445.1810.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lavipharm is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of -0.72 means the investor is paying €-0.72 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Lavipharm S.A:

  • The EOD is -0.614. Bad. Book ratio is negative. -2
  • The MRQ is -0.724. Bad. Book ratio is negative. -2
  • The TTM is -0.930. Bad. Book ratio is negative. -2
Trends
Current periodCompared to+/- 
EOD-0.614MRQ-0.724+0.110
MRQ-0.724TTM-0.930+0.206
TTM-0.930YOY-0.644-0.286
TTM-0.9305Y-0.445-0.486
5Y-0.44510Y-0.4450.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lavipharm S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0%0.037-100%-0.0290%-0.0290%
Book Value Growth--0.0530.0530%0.122-57%0.094-44%0.094-44%
Book Value Per Share---0.570-0.5700%-0.684+20%-0.883+55%-0.883+55%
Book Value Per Share Growth----0%0.066-100%0.040-100%0.040-100%
Current Ratio--1.1461.132+1%1.274-10%1.182-3%1.182-3%
Debt To Asset Ratio--1.1841.1840%1.229-4%1.324-11%1.324-11%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0560.015+270%0.038+46%0.040+39%0.040+39%
Eps Growth----0.6280%-179.6670%-37.8380%-37.8380%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%0.033-100%0.028-100%0.028-100%
Operating Margin----0%0.037-100%0.054-100%0.054-100%
Operating Ratio----0%0.290-100%0.642-100%0.642-100%
Pb Ratio-0.614+15%-0.724-0.930+29%-0.644-11%-0.445-39%-0.445-39%
Pe Ratio6.270-18%7.389-6.390+186%2216.346-100%445.181-98%445.181-98%
Price Per Share0.350-18%0.4130.530-22%0.433-5%0.322+28%0.322+28%
Profit Growth---5.250-144.272+2648%-37851.457+720880%-7986.317+152020%-7986.317+152020%
Quick Ratio--0.5520.587-6%0.733-25%0.680-19%0.680-19%
Return On Assets--0.0180.005+270%0.019-4%0.016+11%0.016+11%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share----0%0.037-100%-0.0290%-0.0290%
Usd Book Value---10215565.000-10215565.0000%-12248995.000+20%-15824876.885+55%-15824876.885+55%
Usd Book Value Change Per Share----0%0.039-100%-0.0300%-0.0300%
Usd Book Value Per Share---0.600-0.6000%-0.719+20%-0.929+55%-0.929+55%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0590.016+270%0.040+46%0.042+39%0.042+39%
Usd Price Per Share0.368-18%0.4340.558-22%0.456-5%0.339+28%0.339+28%
Usd Profit--1000401.250270229.375+270%1026187.500-3%843914.413+19%843914.413+19%
Usd Revenue----0%10244508.750-100%7768800.189-100%7768800.189-100%
Usd Total Gains Per Share----0%0.039-100%-0.0300%-0.0300%
 EOD+2 -2MRQTTM+7 -4YOY+11 -145Y+13 -810Y+13 -8

3.2. Fundamental Score

Let's check the fundamental score of Lavipharm S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.270
Price to Book Ratio (EOD)Between0-1-0.614
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.552
Current Ratio (MRQ)Greater than11.146
Debt to Asset Ratio (MRQ)Less than11.184
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.018
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Lavipharm S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.360
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
 As reported
Total Liabilities -
Total Stockholder Equity+ -
Total Assets = -

Assets

Total Assets-
Total Current Assets28,841
Long-term Assets28,841
Total Current Assets
Net Receivables 13,901
Inventory 11,523
Other Current Assets 676
Total Current Assets  (as reported)28,841
Total Current Assets  (calculated)26,100
+/- 2,741
Long-term Assets
Property Plant Equipment 17,315
Long-term Assets  (as reported)0
Long-term Assets  (calculated)17,315
+/- 17,315

Liabilities & Shareholders' Equity

Total Current Liabilities25,171
Long-term Liabilities-
Total Stockholder Equity-
Total Current Liabilities
Accounts payable 5,386
Other Current Liabilities 4,776
Total Current Liabilities  (as reported)25,171
Total Current Liabilities  (calculated)10,162
+/- 15,009
Long-term Liabilities
Deferred Long Term Liability 1,948
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)1,948
+/- 1,948
Total Stockholder Equity
Common Stock5,108
Retained Earnings -33,198
Other Stockholders Equity 16,635
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)-11,455
+/- 11,455
Other
Net Tangible Assets -9,181



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-30
> Total Assets 
44,808
44,808
45,404
45,404
41,897
41,897
43,954
43,954
0
49,422
0
50,075
0
50,638
0
52,631
0
0
0
0
000052,631050,638050,075049,422043,95443,95441,89741,89745,40445,40444,80844,808
   > Total Current Assets 
19,866
19,866
20,506
20,506
18,941
18,941
20,913
20,913
21,085
21,085
22,415
22,415
23,342
23,342
26,478
26,478
25,961
25,961
28,841
28,841
28,84128,84125,96125,96126,47826,47823,34223,34222,41522,41521,08521,08520,91320,91318,94118,94120,50620,50619,86619,866
       Cash And Cash Equivalents 
2,348
2,348
3,340
3,340
1,842
1,842
2,191
2,191
0
1,732
0
1,726
0
1,932
0
2,214
0
0
0
0
00002,21401,93201,72601,73202,1912,1911,8421,8423,3403,3402,3482,348
       Short-term Investments 
0
0
0
0
12
12
44
44
0
0
0
0
0
0
0
0
0
0
0
0
000000000000444412120000
       Net Receivables 
10,752
10,752
11,886
11,886
11,867
11,867
11,751
11,751
12,298
12,298
11,666
11,666
12,203
12,203
14,420
14,420
14,447
14,447
13,901
13,901
13,90113,90114,44714,44714,42014,42012,20312,20311,66611,66612,29812,29811,75111,75111,86711,86711,88611,88610,75210,752
       Inventory 
5,473
5,473
5,029
5,029
4,842
4,842
5,569
5,529
6,063
6,008
8,331
8,331
8,419
8,419
9,266
9,266
9,240
9,240
11,523
11,523
11,52311,5239,2409,2409,2669,2668,4198,4198,3318,3316,0086,0635,5295,5694,8424,8425,0295,0295,4735,473
       Other Current Assets 
1,293
1,293
251
251
378
378
1,358
1,358
949
949
669
669
769
769
577
577
635
635
676
676
6766766356355775777697696696699499491,3581,3583783782512511,2931,293
   > Long-term Assets 00000000000000000000
       Property Plant Equipment 
15,276
15,276
15,370
15,370
15,329
15,329
15,935
15,240
17,188
16,437
17,099
17,099
17,049
17,049
16,989
16,989
17,565
17,565
17,315
17,315
17,31517,31517,56517,56516,98916,98917,04917,04917,09917,09916,43717,18815,24015,93515,32915,32915,37015,37015,27615,276
       Intangible Assets 
2,016
2,016
1,828
1,828
1,850
1,850
1,780
3,331
0
3,413
0
3,227
0
3,492
0
3,292
0
0
0
0
00003,29203,49203,22703,41303,3311,7801,8501,8501,8281,8282,0162,016
> Total Liabilities 
64,746
64,746
65,749
65,749
61,397
61,397
62,848
62,874
0
63,824
0
62,315
0
62,941
0
62,337
0
0
0
0
000062,337062,941062,315063,824062,87462,84861,39761,39765,74965,74964,74664,746
   > Total Current Liabilities 
19,497
19,497
21,844
21,844
14,666
14,666
16,736
16,736
17,355
17,355
17,273
17,273
18,803
18,803
20,272
20,272
23,232
23,232
25,171
25,171
25,17125,17123,23223,23220,27220,27218,80318,80317,27317,27317,35517,35516,73616,73614,66614,66621,84421,84419,49719,497
       Short-term Debt 
1,111
1,111
2,033
2,033
1,036
1,036
1,529
776
0
1,239
0
457
0
1,133
0
1,678
0
0
0
0
00001,67801,133045701,23907761,5291,0361,0362,0332,0331,1111,111
       Short Long Term Debt 
1,111
1,111
2,033
2,033
1,036
1,036
1,529
1,529
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,5291,5291,0361,0362,0332,0331,1111,111
       Accounts payable 
2,215
2,215
2,714
2,714
2,575
2,575
3,478
3,478
4,832
4,832
5,074
5,074
2,742
2,742
3,562
3,562
4,162
4,162
5,386
5,386
5,3865,3864,1624,1623,5623,5622,7422,7425,0745,0744,8324,8323,4783,4782,5752,5752,7142,7142,2152,215
       Other Current Liabilities 
5,644
5,644
5,967
5,967
4,206
4,206
5,937
5,937
6,401
6,401
6,105
6,105
4,124
4,124
4,362
4,362
4,223
4,223
4,776
4,776
4,7764,7764,2234,2234,3624,3624,1244,1246,1056,1056,4016,4015,9375,9374,2064,2065,9675,9675,6445,644
   > Long-term Liabilities 00000000000000000000
       Deferred Long Term Liability 
1,080
1,080
980
980
817
817
856
856
952
952
944
944
1,334
1,334
1,354
1,354
1,825
1,825
1,948
1,948
1,9481,9481,8251,8251,3541,3541,3341,3349449449529528568568178179809801,0801,080
> Total Stockholder Equity
-19,919
-19,919
-20,324
-20,324
-19,529
-19,529
-18,920
-18,920
0
-14,402
0
-12,240
0
-12,303
0
-9,706
0
0
0
0
0000-9,7060-12,3030-12,2400-14,4020-18,920-18,920-19,529-19,529-20,324-20,324-19,919-19,919
   Common Stock
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
51,081
5,108
5,108
5,1085,10851,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,08151,081
   Retained Earnings -33,198-33,198-159,959-159,959-161,675-161,675-162,122-162,122-164,265-164,265-149,901-164,277-154,419-171,145-169,604-169,604-172,462-172,462-169,907-169,907
   Capital Surplus 
0
0
0
0
0
0
0
84,418
0
84,418
0
84,418
0
84,418
0
84,418
0
0
0
0
000084,418084,418084,418084,418084,4180000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
14,489
14,489
16,639
16,639
14,576
14,576
16,726
16,726
14,376
14,376
16,526
16,526
14,320
14,320
16,470
16,470
14,484
14,484
16,635
16,635
16,63516,63514,48414,48416,47016,47014,32014,32016,52616,52614,37614,37616,72616,72614,57614,57616,63916,63914,48914,489



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue-
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense--
Operating Income-0
 
Operating Expense (+$)
Research Development-
Selling General Administrative-
Selling And Marketing Expenses-
Operating Expense-0
 
Net Interest Income (+$)
Interest Income-
Interest Expense-0
Net Interest Income-0
 
Pretax Income (+$)
Operating Income-
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-0
EBIT - interestExpense = 4,510
1,019
0
Interest Expense0
Earnings Before Interest and Taxes (ebit)4,5100
Earnings Before Interest and Taxes (ebitda)-
 
After tax Income (+$)
Income Before Tax-
Tax Provision--
Net Income From Continuing Ops-0
Net Income-
Net Income Applicable To Common Shares1,723
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-4,908
Total Other Income/Expenses Net-0
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
0R40.LSE
25 minutes ago

I found you a Death Cross on the daily chart of 0R40.LSE.

0R40.LSE Daily Candlestick Chart
0QGU.LSE
29 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.LSE.

0QGU.LSE Daily Candlestick Chart
0QHL.LSE
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QHL.LSE.

0QHL.LSE Daily Candlestick Chart
0QGU.IL
30 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0QGU.IL.

0QGU.IL Daily Candlestick Chart
0Q7S.LSE
32 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0Q7S.LSE.

0Q7S.LSE Daily Candlestick Chart
0O8F.LSE
34 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0O8F.LSE.

0O8F.LSE Daily Candlestick Chart
0NX0.LSE
35 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0NX0.LSE.

0NX0.LSE Daily Candlestick Chart
0MPM.LSE
42 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 0MPM.LSE.

0MPM.LSE Daily Candlestick Chart
0MPJ.LSE
43 minutes ago

I found you a Golden Cross on the daily chart of 0MPJ.LSE.

0MPJ.LSE Daily Candlestick Chart
0MLH.IL
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0MLH.IL.

0MLH.IL Daily Candlestick Chart
0J6X.LSE
49 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of 0J6X.LSE.

0J6X.LSE Daily Candlestick Chart
0IXZ.LSE
50 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IXZ.LSE.

0IXZ.LSE Daily Candlestick Chart
0IT3.IL
52 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0IT3.IL.

0IT3.IL Daily Candlestick Chart
0HAH.LSE
54 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0HAH.LSE.

0HAH.LSE Daily Candlestick Chart
0H3T.LSE
55 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0H3T.LSE.

0H3T.LSE Daily Candlestick Chart
0EEE.LSE
55 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0EEE.LSE.

0EEE.LSE Daily Candlestick Chart
0FM1.LSE
58 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0FM1.LSE.

0FM1.LSE Daily Candlestick Chart
0DJI.LSE
59 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0DJI.LSE.

0DJI.LSE Daily Candlestick Chart
JSCP.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JSCP.NYSE ARC.

JSCP.NYSE ARC Daily Candlestick Chart
JPMB.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPMB.NYSE ARC.

JPMB.NYSE ARC Daily Candlestick Chart
JPIN.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JPIN.NYSE ARC.

JPIN.NYSE ARC Daily Candlestick Chart
JIGB.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JIGB.NYSE ARC.

JIGB.NYSE ARC Daily Candlestick Chart
JHMD.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of JHMD.NYSE ARC.

JHMD.NYSE ARC Daily Candlestick Chart
IXUS.NASDAQ
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IXUS.NASDAQ.

IXUS.NASDAQ Daily Candlestick Chart
ISWN.NYSE ARC
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ISWN.NYSE ARC.

ISWN.NYSE ARC Daily Candlestick Chart